Biosensor– tag –
-
Business Trends
Philips Expands Open Monitoring Ecosystem with Wearable Biosensors through Partnerships with Singapore-Based Respiree and smartQare for Out-of-Hospital Care
G-MedTech Netherlands Overview Philips has expanded its open monitoring ecosystem through partnerships with Singapore-based Respiree (wearable biosensor technology for continuous cardiopulmonary monitoring) and smartQare (viQtor and Heal... -
New Technology
Advances and Challenges in Wearable Sensors for Health Monitoring: Applications of Tear Glucose Contact Lenses and Core Body Temperature T-Sensors
ACS Publications (Review Article) International Overview This review article explores the latest advancements and challenges in wearable sensors for health monitoring. It highlights the development and application of wireless soft smart ... -
Market Trends
Nanoparticle-Based Biosensors for Shigella Monitoring in Food Safety: Advances in High-Sensitivity and Rapid Detection Highlighted in Key Review
MDPI (Review Article) International Overview This review article outlines advancements in nanoparticle-based biosensors for rapid and highly sensitive detection of foodborne pathogen Shigella spp. It comprehensively discusses various det... -
New Technology
Wearable Multi-Analyte Biosensors Revolutionize Diabetes Monitoring and Personalized Medicine: A Comprehensive Review of Nanostructured Electrodes and Flexible Substrate Engineering
PMC (Review Article) International Overview This review article details the path to commercializing minimally and non-invasive glucose monitoring, alongside advances in non-invasive real-time analysis of sweat, saliva, tears, and interst... -
Market Trends
iRhythm Acquires VitalConnect for $287.5 Million, Expanding Wearable Multi-Parameter Cardiac Monitoring Platform
G-MedTech America Overview iRhythm has entered a definitive agreement to acquire VitalConnect, a leader in wearable biosensor technology and ambulatory cardiac monitoring, for approximately $287.5 million. VitalConnect's FDA-cleared plat... -
Market Trends
Abbott Secures CE Mark for Libre Duo Glucose-Ketone Sensor, Accelerates European Rollout of Consumer Lingo Biosensor
FreeStyle Libre Summer 2026 update Europe Overview Abbott obtained the European CE Mark in May 2026 for Libre Duo and Libre Duo 10 Day, capable of measuring both glucose and ketones for 15 days, with European market launch planned within... -
Business Trends
Abbott and Google Health Announce Multi-Year Partnership to Revolutionize Personal Metabolic Health Management with AI-Powered Glucose Insights
PR Newswire USA Overview Abbott and Google Health have announced a multi-year partnership to integrate glucose insights from Abbott's Lingo biowearables with Google's AI and consumer technology, aiming to make personalized metabolic heal... -
New Technology
FDA Approves Non-Invasive Biomarker Imaging Technology for Early Cardiovascular Disease Detection with 98.4% Sensitivity via Retinal Scan
news-today.us USA Overview The FDA has approved a groundbreaking non-invasive biomarker imaging technology capable of detecting subtle vascular inflammation during routine health check-ups. This optical biosensor platform achieves 98.4% ... -
Market Trends
Dexcom Stelo Wins FDA Approval as First Prescription-Free OTC Continuous Glucose Monitor for Non-Insulin Users
Dexcom (via Facebook) USA Overview Dexcom's Stelo glucose biosensor system has received FDA approval as the first over-the-counter (OTC) continuous glucose monitor (CGM) for adults aged 18 and older who do not use insulin. This landmark ... -
New Technology
High-Accuracy Growth-Coupled Metabolic Biosensor Achieves 0.88-1.00 Precision in COVID-19 Prognosis and Diagnosis
bioRxiv USA Overview A novel workflow has successfully engineered and characterized growth-coupled metabolic biosensors demonstrating high accuracy for disease prognosis and diagnosis, exemplified with COVID-19. The top-performing sensor...